Guillaume Wendt serves as an Evidence Generation Director for Medical Germany at Novartis Deutschland. In this role, he leads a multidisciplinary team of approximately 90 experts, contributing to the ongoing evolution of clinical research and evidence generation through a long-term and strategic lens.

His work involves shaping integrated evidence strategies that combine clinical research, real-world evidence (RWE), and AI-enabled analytics.